Health care costs among type 2 diabetes mellitus patients initiating glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1425
https://www.valueinhealthjournal.com/article/S1098-3015(14)01476-4/fulltext
Section Title :
Diabetes/Endocrine Disorders I
Section Order :
898
First Page :
A244
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01476-4&doi=10.1016/j.jval.2014.03.1425